A staging system for hepatocellular carcinoma: Prognostic factors in Ugandan patients
- 1 May 1975
- Vol. 35 (5), 1357-1364
- https://doi.org/10.1002/1097-0142(197505)35:5<1357::aid-cncr2820350518>3.0.co;2-8
Abstract
A staging scheme for hepatocellular carcinoma was presented at an International Symposium on Liver Cancer in Kampala, Uganda in 1971. Historical, clinical, and laboratory aspects of that staging scheme were examined for prognostic significance in 72 untreated patients with this disease studied at the Uganda Cancer Institute. The median survival for the entire group was 1 month. The presence of a serum bilirubin concentration of greater than 2 mg/100 ml or weight loss greater than 25% of body weight were the poorest prognostic features. Other factors with prognostic significance were visible abdominal collateral circulation, ascites, tumor differentiation, and serum levels of alkaline phosphatase, SGOT, alpha fetoprotein, and proline hydroxylase. A modified staging scheme is presented which defines three prognostically different groups of Ugandan patients. It is hoped this staging scheme will serve as a stimulus for analysis of similar prognostic features in other populations of patients with hepatocellular carcinoma.Keywords
This publication has 8 references indexed in Scilit:
- Serum alpha-fetoprotein in 184 ugandan patients with hepatocellular carcinoma.Clinical, laboratory, and histopathologic correlationsCancer, 1974
- Ectopic production of human chorionic gonadotropin in ugandan patients with hepatocellular carcinomaCancer, 1973
- Hemagglutination Assay for Antigen and Antibody Associated with Viral HepatitisScience, 1970
- Malignant hepatoma in the BantuCancer, 1970
- Primary carcinoma of the liver in Ethiopia. A study of 38 cases proved at post-mortem examinationBritish Journal of Cancer, 1970
- Virus-like Antigen, Antibody, and Antigen-Antibody Complexes in Hepatitis Measured by Complement FixationScience, 1969
- Hepatic Artery Infusion Chemotherapy in HepatomaBMJ, 1968
- Five years' experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in womenAmerican Journal of Obstetrics and Gynecology, 1961